entertainment -WSS

entertainment

author：hotspot 2025-08-11 02:12:35 - browse：627

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

Alnylam Pharmaceuticals said Thursday that sales of its treatments for rare diseases grew 43% in the second quarter compared to the year-ago period, as the biotech prepares for a key meeting with the Food and Drug Administration in September.

Net product sales in the quarter were $306 million, led by Amvuttra, the company’s RNAi treatment for hereditary ATTR, with sales of $132 million, exceeding Wall Street forecasts. Sales of Onpattro, its older medicine for hereditary ATTR, were $91 million, slightly less than expectations.

The FDA has scheduled a meeting of outside experts on Sept. 13 to discuss the company’s application to expand the indication for Onpattro to include ATTR-CM, a related condition that affects the heart. The FDA decision is due by Oct. 8. An expansion would open a much larger market for the drug than its current approval, which largely targets nerve-related damage.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： WATCH: Why do fingernails fall off when they're damaged?

leisure time

focus

WSS

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

5 shark bites reported on Long Island as officials deploy surveillance drones

China dismisses criticism of top diplomat's comments appearing to push for race

Adele warns fans about throwing things at performers onstage

WATCH: Why do fingernails fall off when they're damaged?

The strategy behind pharma's lawsuits over drug pricing reform

hotspot

entertainment

hotspot

New air purifier tech could be key to improving indoor air quality

Disclosing genetic information: not as worrisome as once feared

Medical records are filled with copy

CDC concerned about possible undetected monkeypox spread in U.K.

Jerome Adams on the need for new antivirals for Covid

Ask STAT: What do you want to know about ChatGPT in medicine?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Following judge's order, DOJ releases slightly less

How to save PrEP access — and even expand it

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

leisure time

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

New guidelines on severe brain injury complicate already difficult decisions

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

Why are elite athletes different? Take a look at their microbes

Death of patient in Alzheimer’s trial raises question of possible risks

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

leisure time

focus

focus

entertainment